Author:
Strumidło Agnieszka,Skiba Sylwia,Scott Rodney J.,Lubiński Jan
Publisher
Springer Science and Business Media LLC
Subject
Genetics (clinical),Oncology
Reference30 articles.
1. http://www.who.int/cancer/detection/breastcancer/en/index1.html .
2. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M. Parkin D M, Forman D, bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012, Int. J. Cancer. 2015;136:E359–86.
3. Kluzek K, Białkowska A, Koczorowska A. Poly(ADP-ribose) polymerase (PARP) inhibitors in BRCA1/2 cancer therapy. Postepy Hig Med Dosw. 2012;66:372–84.
4. Konecny GE, Kristeleit RS. PARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directions. Br J Cancer. 2016;115:1157–73.
5. Vos S, Vesuna F, Raman V, van Diest PJ, van der Groep P. miRNA expression patterns in normal breast tissue and invasive breast cancers of BRCA1 and BRCA2 germ-line mutation carriers. Oncotarget. 6:31.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献